Acute chest pain syndrome during bleomycin infusions

Area of Science:

• Oncology
• Pharmacology
• Cardiology

Background:

• Bleomycin is an antineoplastic agent used in cancer treatment.
• Adverse events associated with bleomycin therapy require careful monitoring.
• Understanding drug-induced syndromes is crucial for patient safety.

Purpose of the Study:

• To describe a specific adverse event observed during bleomycin infusions.
• To characterize the incidence, presentation, and management of bleomycin-induced chest pain.
• To evaluate the implications for continued bleomycin therapy.

Main Methods:

• Observational study of patients receiving bleomycin.
• Clinical evaluation of reported chest pain episodes.
• Diagnostic workup including electrocardiography and radiography.

Main Results:

• 12 episodes of severe chest pain occurred in 2.8% of patients during bleomycin infusions.
• Pain was sudden, substernal, or pleuritic, with minimal associated symptoms.
• Diagnostic evaluations were largely unrevealing; some cases showed pericarditis or pleural effusion.
• The syndrome was self-limited or responsive to analgesics; bleomycin discontinuation was not always necessary.

Conclusions:

• Chest pain during bleomycin infusion suggests a potential drug effect.
• The syndrome is generally benign with no long-term sequelae.
• Recurrence is uncommon, and further bleomycin courses are not contraindicated.